Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies to target the Hedgehog signaling pathway for cancer therapy
Minhang Xin, Xingyue Ji, Ladie Kimberly De La Cruz, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 3, pp. 870-913
Closed Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments
Kuo‐Shyang Jeng, Chiung‐Fang Chang, Shu-Sheng Lin
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 758-758
Open Access | Times Cited: 180
EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
Xuan Zhu, Lijie Chen, Ling Liu, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 173
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 145
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 106
Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Ngoc Minh Nguyen, Jungsook Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1733-1733
Open Access | Times Cited: 86
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy
Artem Blagodatski, Margarita Yatsunskaya, Valeriia Mikhailova, et al.
Oncotarget (2018) Vol. 9, Iss. 49, pp. 29259-29274
Open Access | Times Cited: 124
Enantioselective Formal C(sp3)−H Bond Activation in the Synthesis of Bioactive Spiropyrazolone Derivatives
Houhua Li, Rajesh Gontla, Jana Flegel, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 1, pp. 307-311
Closed Access | Times Cited: 118
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Ana Bela Sarmento‐Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 47, pp. 100646-100646
Closed Access | Times Cited: 112
C−H Bond Activation for the Synthesis of Heterocyclic Atropisomers Yields Hedgehog Pathway Inhibitors
Gang Shan, Jana Flegel, Houhua Li, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 43, pp. 14250-14254
Closed Access | Times Cited: 100
Hedgehog Signaling Pathway and Autophagy in Cancer
Xian Zeng, Dianwen Ju
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2279-2279
Open Access | Times Cited: 96
Misactivation of Hedgehog signaling causes inherited and sporadic cancers
David R. Raleigh, Jeremy F. Reiter
Journal of Clinical Investigation (2019) Vol. 129, Iss. 2, pp. 465-475
Open Access | Times Cited: 81
A Multistage Halogen Bond Catalyzed Strain-Release Glycosylation Unravels New Hedgehog Signaling Inhibitors
Chunfa Xu, Charles C. J. Loh
Journal of the American Chemical Society (2019) Vol. 141, Iss. 13, pp. 5381-5391
Closed Access | Times Cited: 77
Regulation of signaling pathways in hair follicle stem cells
Xiaoxiang Wang, Yinghui Liu, Jia He, et al.
Burns & Trauma (2022) Vol. 10
Open Access | Times Cited: 50
Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy
Junfeng Fang, Yanqing Liu, Yi‐Wen Chen, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 5991-6007
Open Access | Times Cited: 70
Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment
Jinghui Zhang, Jiajun Fan, Xian Zeng, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 3, pp. 609-620
Open Access | Times Cited: 67
The Role of Smoothened in Cancer
Kuo‐Shyang Jeng, I‐Shyan Sheen, Chuen‐Miin Leu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6863-6863
Open Access | Times Cited: 54
Pharmacological properties and mechanism insights of Moroccan anticancer medicinal plants: What are the next steps?
Abdelhakim Bouyahya, Omar Belmehdi, Abdelaziz Benjouad, et al.
Industrial Crops and Products (2020) Vol. 147, pp. 112198-112198
Closed Access | Times Cited: 51
Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma
Liqing Qiu, Jing Yue, Lingyu Ding, et al.
Cancer Letters (2022) Vol. 546, pp. 215860-215860
Closed Access | Times Cited: 34
Cholesterol Metabolism in Cancer and Cell Death
Fangquan Chen, Yanjiao Lu, Junhao Lin, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 102-140
Closed Access | Times Cited: 19
Divergent and gram-scale syntheses of (–)-veratramine and (–)-cyclopamine
Hou Wen-long, Hao Lin, Yanru Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Design of Hedgehog pathway inhibitors for cancer treatment
Jitender Bariwal, Virender Kumar, Yuxiang Dong, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 3, pp. 1137-1204
Open Access | Times Cited: 47
Medulloblastoma: Molecular understanding, treatment evolution, and new developments
Xiaohua Liu, Chunyong Ding, Wenfu Tan, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107516-107516
Closed Access | Times Cited: 44
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth
Ludovica Lospinoso Severini, Deborah Quaglio, Irene Basili, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1518-1518
Open Access | Times Cited: 43
Repurposing antifungal drugs for cancer therapy
Ningna Weng, Zhe Zhang, Yunhan Tan, et al.
Journal of Advanced Research (2022) Vol. 48, pp. 259-273
Open Access | Times Cited: 27
Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2
Lan Yang, Jenny Jie Chen, Brian Sheng-Xian Teo, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 01, pp. 217-230
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top